Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection

Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an... ABBREVIATIONSBMmarrowCBB(s)cord blood bank(s)CBU(s)cord blood unit(s)DLI(s)donor lymphocyte infusion(s)INTinternationalOMOneMatchPBSC(s)peripheral blood stem/progenitor cell(s)TNCtotal nucleated cell countIncreasing numbers of patients are deemed eligible for hematopoietic cell transplantation, including older patients with comorbidities, due to improved supportive care and the introduction of reduced‐intensity conditioning regimens. Moreover, evolving indications for allogeneic transplant include acute myeloid leukemia at earlier stages of disease, myelodysplastic syndrome, and myeloproliferative disorders. As the number of available sibling donors declines due to smaller family size in recent decades and potential issues related to donor eligibility in older siblings, transplant centers continue to rely heavily on unrelated donors and cord blood units (CBUs). Canadian transplant centers typically prefer allele matching of prospective donors at HLA‐A, ‐B, ‐C, ‐DRB1, and ‐DQB1 loci, with the hope of identifying 10 of 10 HLA‐matched donors. While HLA match level between donor/recipient pairs is considered to be the dominant factor in the selection of unrelated donors, the extent to which additional factors such as sex and donor age influence donor choice remains unclear and the impact of patient ethnicity on donor matching in Canada is unknown. While OneMatch (OM) search specialists can assist in allogeneic search strategies, donor selection is ultimately the responsibility of Canadian transplant centers.With http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Transfusion Wiley

Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection

Loading next page...
 
/lp/wiley/unrelated-donor-choices-for-allogeneic-hematopoietic-cell-oiC0PImm9f
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 AABB
ISSN
0041-1132
eISSN
1537-2995
D.O.I.
10.1111/trf.14458
Publisher site
See Article on Publisher Site

Abstract

ABBREVIATIONSBMmarrowCBB(s)cord blood bank(s)CBU(s)cord blood unit(s)DLI(s)donor lymphocyte infusion(s)INTinternationalOMOneMatchPBSC(s)peripheral blood stem/progenitor cell(s)TNCtotal nucleated cell countIncreasing numbers of patients are deemed eligible for hematopoietic cell transplantation, including older patients with comorbidities, due to improved supportive care and the introduction of reduced‐intensity conditioning regimens. Moreover, evolving indications for allogeneic transplant include acute myeloid leukemia at earlier stages of disease, myelodysplastic syndrome, and myeloproliferative disorders. As the number of available sibling donors declines due to smaller family size in recent decades and potential issues related to donor eligibility in older siblings, transplant centers continue to rely heavily on unrelated donors and cord blood units (CBUs). Canadian transplant centers typically prefer allele matching of prospective donors at HLA‐A, ‐B, ‐C, ‐DRB1, and ‐DQB1 loci, with the hope of identifying 10 of 10 HLA‐matched donors. While HLA match level between donor/recipient pairs is considered to be the dominant factor in the selection of unrelated donors, the extent to which additional factors such as sex and donor age influence donor choice remains unclear and the impact of patient ethnicity on donor matching in Canada is unknown. While OneMatch (OM) search specialists can assist in allogeneic search strategies, donor selection is ultimately the responsibility of Canadian transplant centers.With

Journal

TransfusionWiley

Published: Jan 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial